page_banner

Products

Myoglobin/CK-MB/Troponin I Rapid Combo Test Device (WB/S/P)


Short Description:

The Myoglobin/CK‐MB/Troponin I Rapid Combo Test Device (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of human Myoglobin, CK‐MB and cardiac Troponin I in whole blood, serum or plasma as an aid in the diagnosis of myocardial infarction (MI).



Product Detail

Product Tags

PRINCIPLE

The Myoglobin/CK‐MB/Troponin I Rapid Combo TestDevice (WholeBlood/Serum/ Plasma)is a qualitative, membrane basedimmunoassayfor the detection of Myoglobin,CK‐MB and TroponinI in wholeblood, serumor plasma.Themembrane is pre‐coated with specific capture antibodies in each of the testlineregions of thetest.During testing,the whole blood,serum or plasma specimen reacts with the particlecoated with specific antibodies. The mixture migrates upward on the membrane chromatographicallybycapillary action toreact with specificcapturereagentson the membraneandgeneratea colored line.Thepresence of thiscolored line in the specific test lineregion indicates a positiveresult, while its absenceindicatesa negative result. To serve as a procedural control,a colored line will alwaysappear in the control line region indicating that Proper volume of specimen has been added and membrane wicking has occurred.
REAGENTS
The test containsanti‐Myoglobinantibodycoatedparticles,anti‐CK‐MB antibody coated particles,anti‐Troponin I antibody coatedparticles,andcapture reagents coated on themembrane.

EXPECTED VALUES

The Myoglobin/CK‐MB/Troponin I Rapid Combo Test Device (Whole Blood/Serum/ Plasma) has
been compared with a leading commercial Myoglobin/CK‐MB/T EIA test, demonstrating an overall
accuracy of 98.1% with Myoglobin, 99.8% with CK‐MB, and 98.5% with Troponin I.

PERFORMANCE CHARACTERISTICS

Sensitivity and Specificity

The Myoglobin/CK‐MB/Troponin I Rapid Combo Test Device (Whole Blood/Serum/ Plasma) has

been evaluated with a leading commercial Myoglobin/CK‐MB/Troponin I EIA test using clinical

specimens. The results show that relative to leading EIA tests, the Myoglobin/CK‐MB/Troponin I

Rapid Combo Test Device (Whole Blood/Serum/ Plasma) exhibits 100% sensitivity and 97.8%

specificity for Myoglobin, 100% sensitivity and 99.8% specificity for CK‐MB, and 98.3% sensitivity

and 98.6% specificity for Troponin I.

Myoglobin Test vs. EIA

Method

EIA

 

Total  Results

MYO Test

Positive Negative Positive Negative
Positive59 8  67
 Negative 0356 356

Total Results

59 364 423

Relative Sensitivity: 100% (94.0%‐100%)*

Relative Specificity: 97.8% (95.7%‐99.0%)*

Accuracy: 98.1% (96.3%‐99.2%)* 95% Confidence Interval

CK‐MB Test vs. EIA

Method

EIA

 

Total  Results

CK‐MB Test

Positive Negative Positive Negative
Positive55 156
 Negative 0425425

Total Results

55426481

Relative Sensitivity: 100% (93.4%‐100.0%) *

Relative Specificity: 99.8% (98.7%‐99.9%)*

Accuracy:99.8%(98.8%‐99.9%)* * 95% Confidence Interval

Troponin I Test vs. EIA

Method

EIA

 

Total  Results

cTnI Test

Positive Negative Positive Negative
Positive2287235
 Negative4509513

Total Results

232516748

Relative Sensitivity: 98.3%% (9(97.2%‐99.4%)*5.6%‐ 99.5%)*

Relative Specificity: 98.6% (97.2%‐99.4%)*

Accuracy: 98.5%(97.4%‐99.3%)* * 95% Confidence Interval


  • Previous:
  • Next:


  • Previous:
  • Next: